Vittorio Branchi

8PUBLICATIONS
53CO-AUTHORS
Molecular targetsPredictive and prognostic markersHaematological tumoursTumour immunology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Jul 09, 2025
The Antibody-Drug Conjugate Sacituzumab Govitecan (IMMU-132) Represents a Potential Novel Therapeutic Strategy in Cholangiocarcinoma.

Racha Hosni, Niklas Klümper, Christine Sanders

|Jun 13, 2025
The Antibody-Drug Conjugate Sacituzumab Govitecan (IMMU-132) Represents a Potential Novel Therapeutic Strategy in Cholangiocarcinoma.

Racha Hosni, Niklas Klümper, Christine Sanders

|Apr 24, 2025
Spatial mapping of transcriptomic plasticity in metastatic pancreatic cancer.

Guangsheng Pei, Jimin Min, Kimal I Rajapakshe

|Mar 07, 2024
Transcriptomic Profiling of Plasma Extracellular Vesicles Enables Reliable Annotation of the Cancer-Specific Transcriptome and Molecular Subtype.

Vahid Bahrambeigi, Jaewon J Lee, Vittorio Branchi

|Jun 24, 2022
Diagnostic Potential of Exosomal microRNAs in Colorectal Cancer.

Jonas Dohmen, Alexander Semaan, Makbule Kobilay

|Sep 28, 2021
A Combined TLR7/TLR9/GATA3 Score Can Predict Prognosis in Biliary Tract Cancer.

Vittorio Branchi, Laura Esser, Corinna Boden

Pageof 2

Frequent Collaborators

5 joint publications

Alexander Semaan

4 joint publications

Maria A Gonzalez-Carmona

2 joint publications

Racha Hosni

2 joint publications

Tobias J Weismüller